Dios Lifesciences Private Limited, a active private limited company, was established on 29 July 2011 in New Delhi, Delhi, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U51397DL2011PTC223012. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹1.91 M.
It upholds a compliant status. Employing 85 professional, Its leadership includes Manish Srivastava (Director), Geeta Arora (Director), Gagan Taneja (Director). Past directors included Neeti Srivastav, Manish Srivastava, Hiral Arora. It holds ₹9.30 M open charges and no settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-1/E-23, Mohan Co-Operative Industrial Estate,, Mathura Road, South East, New Delhi, Delhi, 110044.
U51397DL2011PTC223012
223012
29 July 2011
₹3.00 M
₹1.91 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Dios Lifesciences Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Srivastava | Director | 30 May 2022 | Current |
| Geeta Arora | Director | 22 May 2023 | Current |
| Gagan Taneja | Director | 29 Jul 2011 | Current |
| Jai Sheel Chabra | Director | 29 Jul 2011 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 May 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 26 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dios Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.28% increase. The company also saw a substantial improvement in profitability, with a 316.4% increase in profit. The company's net worth moved up by a moderate rise of 5.87%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Dios Lifesciences had a public holding of 1.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹9,300,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Aug 2023 | Hdfc Bank Limited | ₹3.10 M | Open |
| 31 Aug 2023 | Hdfc Bank Limited | ₹3.10 M | Open |
| 21 Aug 2023 | Hdfc Bank Limited | ₹3.10 M | Open |
Explore comprehensive loan charge details -
Dios Lifesciences has a workforce of 85 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dios Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dios Lifesciences's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Dios Lifesciences Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Dios Lifesciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was documented.
A charge with Hdfc Bank Limited amounted to Rs. 3.10 M with Charge ID 100772378 was registered on 31 Aug 2023. was recorded as a recent event.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 3.10 M with Charge ID 100772369 was registered on 31 Aug 2023. was documented.
The activity A charge with Hdfc Bank Limited amounted to Rs. 3.10 M with Charge ID 100772384 was registered on 21 Aug 2023. was completed.
Progress on Geeta Arora was appointed as a Director was appointed as a Director on 22 May 2023 & has been associated with this company since 2 years 7 months . was documented.
The CIN of Dios Lifesciences Private Limited is U51397DL2011PTC223012.
Dios Lifesciences Private Limited is headquartered at B-1/E-23, Mohan Co-Operative Industrial Estate,, Mathura Road, South East, New Delhi, Delhi, 110044.
Dios Lifesciences Private Limited was incorporated on 29 July 2011.
The current directors of Dios Lifesciences Private Limited are
The primary industry of Dios Lifesciences Private Limited is Trade.
Dios Lifesciences Private Limited is unlisted.
The authorized capital of Dios Lifesciences Private Limited is ₹3.00 M, and the paid-up capital is ₹1.91 M.
The compliance status of Dios Lifesciences Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX